Sheathless Use of the New Portico ™ Transcatheter Aortic Valve System in Complex Vascular Access Cases
IntroductionThe Policlinico di Monza (Milan, Italy) is a leader in the endovascular treatment of structural heart disease, accounting for more than 2500 procedures including transcatheter aortic valve implantation (TAVI), atrial septal defects (ASD), patent foramen ovale (PFO) and renal denervation.The team has experience with various TAVI devices and has completed more than 700 TAVI procedures. Most recently, the team incorporated the innovative Portico ™ transcatheter aortic valve system (St. Jude Medical).
Source: Radcliffe Cardiology - Category: Cardiology Authors: mehul Source Type: research
More News: Atrial Septal Defect | Cardiology | Heart | Heart Disease | Hole in the Heart | Patent Foramen Ovale